🌟 Join us on October 15 for a groundbreaking Externally-Led Patient-Focused Drug Development (EL-PFDD) meeting on Dementia with Lewy Bodies (DLB), hosted by LBDA in collaboration with the Alzheimer’s Association! 🧠✨ This is a unique chance for the FDA and key stakeholders to hear directly from those impacted by DLB—patients, caregivers, and families—about their experiences and the treatments that matter most. 💻 It’s a FREE virtual event open to everyone! Check out the FDA’s EL-PFDD website and LBDA’s page for more details, and don’t forget to spread the word! Together, we can make a difference. 💙 #DLB #PatientVoices #AlzheimersAwareness